JP2024526149A - 消化管への活性物質の投与を制御する方法 - Google Patents

消化管への活性物質の投与を制御する方法 Download PDF

Info

Publication number
JP2024526149A
JP2024526149A JP2023578776A JP2023578776A JP2024526149A JP 2024526149 A JP2024526149 A JP 2024526149A JP 2023578776 A JP2023578776 A JP 2023578776A JP 2023578776 A JP2023578776 A JP 2023578776A JP 2024526149 A JP2024526149 A JP 2024526149A
Authority
JP
Japan
Prior art keywords
capsule
hpmc
acid
sample
gellan gum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023578776A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024526149A5 (cg-RX-API-DMAC7.html
Inventor
ベラマイン,アワテフ
ホワイト,タイラー
ダーキー,シェーン
Original Assignee
ロンザ・グリーンウッド・エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ロンザ・グリーンウッド・エルエルシー filed Critical ロンザ・グリーンウッド・エルエルシー
Publication of JP2024526149A publication Critical patent/JP2024526149A/ja
Publication of JP2024526149A5 publication Critical patent/JP2024526149A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2023578776A 2021-06-24 2022-06-23 消化管への活性物質の投与を制御する方法 Pending JP2024526149A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163214438P 2021-06-24 2021-06-24
US63/214,438 2021-06-24
PCT/US2022/034683 WO2022271922A1 (en) 2021-06-24 2022-06-23 Method to control administration of active substance to the digestive tract

Publications (2)

Publication Number Publication Date
JP2024526149A true JP2024526149A (ja) 2024-07-17
JP2024526149A5 JP2024526149A5 (cg-RX-API-DMAC7.html) 2025-07-16

Family

ID=84544830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023578776A Pending JP2024526149A (ja) 2021-06-24 2022-06-23 消化管への活性物質の投与を制御する方法

Country Status (8)

Country Link
US (1) US20240285699A1 (cg-RX-API-DMAC7.html)
EP (1) EP4340819A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024526149A (cg-RX-API-DMAC7.html)
CN (1) CN117479929A (cg-RX-API-DMAC7.html)
AU (1) AU2022299196A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023027371A2 (cg-RX-API-DMAC7.html)
CA (1) CA3223905A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022271922A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116270523B (zh) * 2023-05-15 2023-08-08 四川厌氧生物科技有限责任公司 一种耐酸的口服双层胶囊及其制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160000722A1 (en) * 2010-05-12 2016-01-07 Harald Greve Dosage form for cineole
EP3028694A1 (en) * 2014-12-02 2016-06-08 Capsugel Belgium NV Dosage form articles for delayed release
JP2016517425A (ja) * 2013-03-14 2016-06-16 セラバイオーム,エルエルシー プロバイオティクス生物及び/又は治療剤の標的化胃腸管デリバリー
US20190388345A1 (en) * 2018-06-22 2019-12-26 Probiotech Llc Method to Improve the Health of the Microbiome in a Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor
WO2020056298A1 (en) * 2018-09-13 2020-03-19 Assembly Biosciences, Inc. Methods and compositions for treating gastrointestinal and inflammatory disorders
WO2020092421A1 (en) * 2018-10-30 2020-05-07 Ranas, Llc Oral delivery of therapeutic mammalian cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2667167C (en) * 2006-10-27 2014-02-18 Pfizer Products Inc. Hydroxypropyl methyl cellulose hard capsules and process of manufacture
BR112012006651B1 (pt) * 2009-09-24 2021-11-03 Capsugel Belgium Nv Cápsula farmacêutica dura resistente a ácido e composição aquosa compreendendo goma de gelano e hpmc
EP3882259B1 (en) * 2015-05-13 2026-01-28 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
EP4480495A3 (en) * 2017-07-10 2025-06-18 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
US20200038215A1 (en) * 2018-08-01 2020-02-06 Ethicon, Inc. Transient implantable device to control absorption of nutrients
MX2022004515A (es) * 2019-10-16 2022-07-12 Capsugel Belgium Nv Metodo y composicion para aumentar la sintesis de proteinas musculares.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160000722A1 (en) * 2010-05-12 2016-01-07 Harald Greve Dosage form for cineole
JP2016517425A (ja) * 2013-03-14 2016-06-16 セラバイオーム,エルエルシー プロバイオティクス生物及び/又は治療剤の標的化胃腸管デリバリー
EP3028694A1 (en) * 2014-12-02 2016-06-08 Capsugel Belgium NV Dosage form articles for delayed release
US20190388345A1 (en) * 2018-06-22 2019-12-26 Probiotech Llc Method to Improve the Health of the Microbiome in a Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor
WO2020056298A1 (en) * 2018-09-13 2020-03-19 Assembly Biosciences, Inc. Methods and compositions for treating gastrointestinal and inflammatory disorders
WO2020092421A1 (en) * 2018-10-30 2020-05-07 Ranas, Llc Oral delivery of therapeutic mammalian cells

Also Published As

Publication number Publication date
AU2022299196A1 (en) 2023-12-21
CA3223905A1 (en) 2022-12-29
BR112023027371A2 (pt) 2024-03-12
CN117479929A (zh) 2024-01-30
EP4340819A4 (en) 2025-04-02
WO2022271922A1 (en) 2022-12-29
EP4340819A1 (en) 2024-03-27
US20240285699A1 (en) 2024-08-29

Similar Documents

Publication Publication Date Title
US7122370B2 (en) Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
JP6464142B2 (ja) プロバイオティクス生物及び/又は治療剤の標的化胃腸管デリバリー
JP3752421B2 (ja) 乳酸菌の安定化のための微細腸溶性コーティング顆粒
US8852631B2 (en) Acid resistant capsules
ES2708811T3 (es) Procedimiento de fabricación de cápsula blanda entérica
TWI584824B (zh) A capsule for delivery to a large intestine and a method of manufacturing the same
TWI543780B (zh) 雙叉乳酸桿菌大腸遞送膠囊及其製造方法
TW202233164A (zh) 緩釋軟膠囊
EP2243487A1 (en) Enteric coated formulation
KR102483912B1 (ko) 연질캡슐형 건강기능식품의 제조방법
US20240285699A1 (en) Method to Control Administration of Active Substance to the Digestive Tract
JPH11302158A (ja) 腸溶性シームカプセルを用いた整腸作用を有する健康食品
JP5997034B2 (ja) キトサン含有組成物及びキトサンコーティング組成物
JP5907796B2 (ja) 腸内環境改善食品
JP5957280B2 (ja) 大腸デリバリーシームレスカプセル製剤及びその製造方法
JP2004250338A (ja) 有用生菌製剤
KR101931638B1 (ko) 셸락 및/또는 그의 염 및 나트륨 전분 글리콜레이트를 포함하는 조성물
RU2783157C2 (ru) Гранулы холестирамина, пероральные композиции холестирамина и их применение
CN117257845A (zh) 靶向投递活益生菌的方法
HK40012186A (en) Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
NZ711298B2 (en) Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250623

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250623

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250708

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260325

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260402

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260701